PharmaCyte Biotech Files 8-K on Security Holder Vote Matters
Ticker: PMCB · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1157075
| Field | Detail |
|---|---|
| Company | Pharmacyte Biotech, Inc. (PMCB) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
PharmaCyte Biotech is holding a shareholder vote.
AI Summary
PharmaCyte Biotech, Inc. filed an 8-K on April 24, 2025, reporting a submission of matters to a vote of security holders. The company, incorporated in Nevada, is involved in the biological products sector and previously operated under the names NuVilex, Inc. and eFoodSafety.com Inc.
Why It Matters
This filing indicates that PharmaCyte Biotech is engaging its shareholders on important corporate decisions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine procedural report regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- PharmaCyte Biotech, Inc. (company) — Registrant
- NuVILEX, INC. (company) — Former Company Name
- eFOODSAFETY COM INC (company) — Former Company Name
- 20250424 (date) — Filing Date
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that a submission of matters to a vote of security holders is being reported.
When was PharmaCyte Biotech, Inc. incorporated?
PharmaCyte Biotech, Inc. was incorporated in Nevada.
What is PharmaCyte Biotech's Standard Industrial Classification (SIC) code?
PharmaCyte Biotech's SIC code is 2836, for Biological Products (No Diagnostic Substances).
What were PharmaCyte Biotech's former company names?
PharmaCyte Biotech was formerly known as NUVILEX, INC. and EFOODSAFETY COM INC.
What is the principal executive office address for PharmaCyte Biotech?
The principal executive offices are located at 3960 Howard Hughes Parkway, Suite 500, Las Vegas, Nevada 89169.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding PharmaCyte Biotech, Inc. (PMCB).